# Trade Mark Journal No.2026/008 20 February 2026

## WO0000001890401 (5,42,44)

Office of origin: United States of America

Date of International Registration:30 October 2025
Date of designation in the UK: 30 October 2025

International priority date claimed: 24 October 2025 (United States of America) (99461947)

Class 5
  Pharmaceutical preparations for the treatment of neuropsychiatric disorders, diseases, and conditions.
Class 42
  Research in the field of brain function, biotechnology, machine learning in psychiatry, neuro-feedback, transcranial magnetic stimulation.
Class 44
  Medical services in the field of neuroscience, neurology, psychiatry, psychology and brain function analysis; provision of medical and healthcare consulting services relating to the brain, drug development, biomarker development; medical testing for diagnostic or treatment purposes in the field of mental health; mental health screening services; mental health services.

Alto Neuroscience, Inc.

Representative: Kelley B. Harrington Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA